AbbVie cuts guidance despite strong Q2 results following $10.9B acquisition
ABBV Abbvie Inc
$257.41 -2.24%
차트·분석 보기 → - 1AbbVie (ABBV) shares fell 3.46% in pre-market trading after the company raised its full-year guidance despite beating Q2 estimates
- 2Net revenue of $16.99B (+10.2%) and adjusted diluted EPS of $3.65 topped estimates of $16.78B and $3.60, respectively
- 3The $0.04 reduction to the midpoint of its 2026 EPS guidance reflects a $0.14 per-share dilution impact from the approximately $10.9B acquisition of Apos
This 3-line summary is compiled from the report below.
Barrons.com +1 View original ↗🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다